SMYD3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-79394
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the C terminal of human SMYD3The immunogen for this antibody is SMYD3. Peptide sequence LHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for SMYD3 Antibody
![Western Blot: SMYD3 Antibody [NBP1-79394]](https://resources.bio-techne.com/images/products/SMYD3-Antibody-Western-Blot-NBP1-79394-img0002.jpg "Western Blot: SMYD3 Antibody [NBP1-79394]")
Western Blot: SMYD3 Antibody [NBP1-79394]
Western Blot: SMYD3 Antibody [NBP1-79394] - MCF-7 whole cell lysates, concentration 0.2-1 ug/ml.Applications for SMYD3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SMYD3
Long Name
Histone-lysine N-methyltransferase SMYD3
Alternate Names
ZMYND1, ZNFN3A1
Gene Symbol
SMYD3
UniProt
Additional SMYD3 Products
Product Documents for SMYD3 Antibody
Product Specific Notices for SMYD3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...